Stocks slumped in March as the Trump administration vowed to move ahead with tariffs that put both Wall Street and Main ...

Financial markets, consumer surveys, and business outlooks show that economic participants are nervous ahead of critical ...

Stocks were lower in afternoon trading Monday, extending a three-day-losing streak, as investors await announcements on a new ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

The view from Melius Research appears to be uncommon, with most analysts polled by Visible Alpha recommending buying or ...

Fannie Mae's latest housing report forecasts that after climbing in Q1, rates on 30-year mortgages will slide the rest of the ...

Tesla shares gained a day ahead of the electric vehicle maker's first-quarter deliveries data expected Wednesday.

The S&P 500 edged 0.4% higher on Tuesday, April 1, ahead of Wednesday's anticipated rollout of reciprocal tariffs by Donald ...

Johnson & Johnson shares fell Tuesday, after the company said a judge rejected its proposed plan to settle thousands of ...

Macy's named a new chief operating officer and CFO and has made other moves within its executive ranks, which the retailer ...

Conservative new channel Newsmax's stock surged again on Tuesday after skyrocketing Monday in its first day of trading.

President Donald Trump's proposed tariffs could raise the cost of some cancer treatments by as much as $10,000, while also raising prices for cheaper everyday drugs, a new analysis has found.